Methylnaltrexone oral/injection and Hepatic impairment
Result of checking the interaction of drug Methylnaltrexone oral/injection and disease Hepatic impairment for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Studies have shown a significant increase in systemic exposure of methylnaltrexone in patients with moderate and severe hepatic impairment, compared to subjects with normal hepatic function. A dosage reduction is recommended in these patients. No dose adjustment is needed in patients with mild hepatic impairment.
Generic Name: methylnaltrexone
Brand Name: Relistor
Synonyms: Methylnaltrexone (oral/injection), Methylnaltrexone
Methylnaltrexone oral/injection - zaburzenia czynności wątroby 
Methylnaltrexone oral/injection - insuficiência hepática 
Methylnaltrexone oral/injection - gangguan hati 
Methylnaltrexone oral/injection - gangguan hati 
Methylnaltrexone oral/injection - insufficienza epatica 
Methylnaltrexone oral/injection - insuffisance hépatique 
Methylnaltrexone oral/injection - Leberfunktionsstörung 
Methylnaltrexone oral/injection - deterioro hepático 
Methylnaltrexone oral/injection - печеночная недостаточность 
Methylnaltrexone oral/injection - karaciğer yetmezliği 
Methylnaltrexone oral/injection - اختلال كبدي 
Methylnaltrexone oral/injection - 肝功能不全